Combination therapy with ribavirin and amantadine in renal transplant patients with chronic hepatitis C virus infection is not superior to ribavirin alone

Journal of Clinical Virology

Volumn 39, Issue 1, 2007, Pages 54-58

  Calanca, Luzia Nigg ^a   Fehr, Thomas ^a   Jochum, Wolfram ^a   Fischer Vetter, Julia ^a   Müllhaupt, Beat ^a   Wüthrich, Rudolf P ^a   Ambühl, Patrice M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Amantadine; HCV infection; Hepatitis C; Hepatopathy; Renal transplantation; Ribavirin

Indexed keywords

AMANTADINE; AMANTADINE SULFATE; CREATININE; LIVER ENZYME; RECOMBINANT ERYTHROPOIETIN; RIBAVIRIN; VIRUS RNA;

ADULT; ANEMIA; ARTICLE; CLEARANCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TOLERABILITY; GRAFT REJECTION; HEPATITIS C; HISTOLOGY; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIVER DISEASE; MAJOR CLINICAL STUDY; MONOTHERAPY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; VIREMIA;

ADULT; AMANTADINE; ANEMIA; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RIBAVIRIN;

EID: 34147178932     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.02.006     Document Type: Article

References (18)

1. Brillanti S., Levantesi F., Masi L., Foli M., and Bolondi L. Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C. Hepatology 32 3 (2000) 630-634
2. Bruchfeld A., Lindahl K., Schvarcz R., and Stahle L. Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis. Ther Drug Monit 24 6 (2002) 701-708
3. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 1 (1976) 31-41
4. De Clercq E. Antiviral drugs in current clinical use. J Clin Virol 30 2 (2004) 115-133
5. Durlik M., Gaciong Z., Rowinska D., Rancewicz Z., Lewandowska D., Kozlowska B., et al. Long-term results of treatment of chronic hepatitis B, C and D with interferon-alpha in renal allograft recipients. Transpl Int 11 Suppl 1 (1998) S135-S139
6. Fabrizi F., Martin P., and Ponticelli C. Hepatitis C virus infection and renal transplantation. Am J Kidney Dis 38 5 (2001) 919-934
7. Fehr T., and Ambühl P.M. Chronic hepatitis virus infections in patients on renal replacement therapy. Nephrol Dial Transplant 19 5 (2004) 1049-1053
8. Fehr T., Riehle H.M., Nigg L., Grüter E., Ammann P., Renner E.L., et al. Evaluation of hepatitis B and hepatitis C virus-infected renal allograft recipients with liver biopsy and noninvasive parameters. Am J Kidney Dis 42 1 (2003) 193-201
9. Fontaine H., Vallet-Pichard A., Equi-Andrade C., Nalpas B., Verkarre V., Chaix M.L., et al. Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C. Transplantation 78 6 (2004) 853-857
10. Guido M., and Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 24 1 (2004) 89-97
11. Hammoud H., Haem J., Laurent B., Alamartine E., Diab N., Defilippis J.P., et al. Glomerular disease during HCV infection in renal transplantation. Nephrol Dial Transplant 11 Suppl 4 (1996) 54-55
12. Hanafusa T., Ichikawa Y., Kishikawa H., Kyo M., Fukunishi T., Kokado Y., et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 66 4 (1998) 471-476
13. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 6 (1995) 696-699
14. Kamar N., Rostaing L., Sandres-Saune K., Ribes D., Durand D., and Izopet J. Amantadine therapy in renal transplant patients with hepatitis C virus infection. J Clin Virol 30 1 (2004) 110-114
15. Kamar N., Sandres-Saune K., Selves J., Ribes D., Cointault O., Durand D., et al. Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology. Am J Kidney Dis 42 1 (2003) 184-192
16. Mangia A., Minerva N., Annese M., Leandro G., Villani M.R., Santoro R., et al. A randomized trial of amantadine and interferon versus interferon alone as initial treatment for chronic hepatitis C. Hepatology 33 4 (2001) 989-993
17. Martin J., Navas S., Fernandez M., Rico M., Pardo M., Quiroga J.A., et al. In vitro effect of amantadine and interferon alpha-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patients. Antiviral Res 42 1 (1999) 59-70
18. Periera B.J., Wright T.L., Schmid C.H., and Levey A.S. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 60 8 (1995) 799-805